Latest news

September 4, 2024
/
News

US FDA Grants Clearance for DaylightRx

US FDA Grants Clearance for SleepioRx
August 8, 2024
/
News
Study Finds Spark Direct Effective in Improving Mood Among Adults With Depression
May 23, 2024
/
News
Running the Next Leg
April 2, 2024
/
News
The mental health system of the future, delivered today
January 2, 2024
/
News

All News

Big Health doubles its ‘lives covered’ as COVID-19 drives demand and adoption of solutions for good mental health
Big Health doubled the number of 'lives covered' in 2020 as demand for mental health solutions increase.
March 31, 2021
/
News
New study finds digital CBT the most cost effective option for poor sleep, when compared to other leading choices
Digital Cognitive Behavioral Therapy (dCBT), as delivered by Sleepio, was found to be the most cost-effective intervention overcoming poor sleep.
December 15, 2020
/
News
First of its kind digital therapeutic research identifies poor sleep as a target for improving depressive symptoms
Digital sleep program, Sleepio, associated with significant improvements in depressive symptoms.
August 19, 2020
/
News
Digital therapy for insomnia could save NHS millions and improve anxiety and depression symptoms
New report finds use of Sleepio delivers high recovery rates, improve mental health outcomes & could save the NHS £56 million over three years.
July 31, 2020
/
News
Landmark Randomized Controlled Trial Demonstrates Efficacy of Daylight™ Digital Therapeutic in Improving Anxiety
71% of Daylight users in the study achieved and maintained remission of Generalized Anxiety Disorder (GAD) by week 10 follow-up, compared to 33% of controls.
July 29, 2020
/
News
Big Health Raises $39 Million in Series B Financing from Gilde Healthcare, Morningside Ventures, Kaiser Permanente Ventures, and Octopus Ventures
Big Health announces $39MM in Series B financing led by Gilde Healthcare and Morningside Ventures; existing investors Kaiser Permanente Ventures & Octopus Ventures.
June 18, 2020
/
News
Let's talk
For all media-related queries, please get in touch with us.
Who we are
Learn about our mission, leadership, advisors, and investors.